Blog - Page 1930 of 5721

FridaySep 06, 2019 10:02 am

QualityStocksNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Announces Board Member Resignation

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, this morning announced that, effective September 6, 2019, Kevin Ma has resigned from its board of directors in order to focus on other business obligations. According to the update, Ma will continue to perform consulting services for Nabis. “Kevin has played an integral part in building the company as it exists today and we sincerely thank him for his dedicated work and support,” Nabis CEO and Director Shay Shnet said in the news release. “We…

FridaySep 06, 2019 9:23 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Gains Approval to List Class A Subordinated Voting Shares on the Toronto Stock Exchange

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday announced that it has received final approval to list its class A subordinated voting shares on the Toronto Stock Exchange (“TSX”). Per the update, the shares will begin trading on the TSX under the ticker symbol “RIV” on September 9 at the opening of markets. The company’s subordinated voting shares will be delisted from the TSX Venture Exchange in conjunction with listing on the TSX. To view the full press release, visit http://ibn.fm/fM3EQ About Canopy Rivers Inc. Canopy Rivers is a unique investment and operating…

ThursdaySep 05, 2019 2:34 pm

QualityStocksNewsBreaks – Why HTC Extraction Systems (TSX.V: HTC) Is ‘One to Watch’

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary extraction and purification systems for biomass, gas and liquid extraction. A recent article discussing the company reads, “HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction,…

ThursdaySep 05, 2019 1:53 pm

QualityStocksNewsBreaks – Earth Science Tech Inc. (ETST) Subsidiary’s Home-Detection Kit Enables Women to Self-Screen for STIs

Earth Science Tech’s (OTCQB: ETST) wholly owned subsidiary Earth Science Pharma Inc. is dedicated to research, with a goal of eradicating sexually transmitted infections (“STIs”). An article discussing the company reads, “Earth Science Pharma is specifically focusing on developing and bringing to market medical devices and vaccines that focus on improving the health of women. Women’s health and access to medical amenities are huge concerns in both developed and developing nations. The company recently launched MSN-2, its first medical device, as a part of its initiative to meet the medical needs of women. . . . MSN-2 is a home…

ThursdaySep 05, 2019 1:47 pm

QualityStocksNewsBreaks – Neutra Corp. (NTRR) Adding Hemp-Derived CBD Product Retail Brand to Portfolio

Neutra (OTCQB: NTRR), an early-stage research and development company focused on modern healthy-living solutions, recently added an up-and-coming retail brand of hemp-based health and nutritional products to its portfolio through the company’s acquisition of VIVIS. An article discussing the company reads, “Neutra’s purchase of VIVIS, an emerging retail brand of hemp-based health and nutritional products, is underway with the signing of a letter of intent (LOI) (http://ibn.fm/VFex6). . . . ‘This acquisition will give Neutra Corp. an even stronger market presence with an established brand already recognized for superiority,’ Neutra president and CEO Sydney Jim stated in a news release.…

ThursdaySep 05, 2019 12:40 pm

QualityStocksNewsBreaks – Marijuana Company of America Inc. (MCOAD) Announces Completion of Reverse Stock Split

Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA, MCOAD) today announced that it began trading on a split-adjusted basis on September 3, 2019. The company announced its proposal for a 1-for-60 reverse stock split on July 31, 2019. According to the update, the company’s common shares, which previously traded under the ticker symbol “MCOA,” began trading on a post-split basis under the symbol “MCOAD.” This will continue for a period of 20 business days, after which the “D” will be removed, and the symbol will revert back to “MCOA.” The reverse stock split affected all issued and…

ThursdaySep 05, 2019 12:19 pm

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Strongly Positioned to Meet Growing Demand for Organic Cannabis

The Green Organic Dutchman participated in the renowned Cannabis Investor Conference held by New West Partners TGOD received a 100 percent organic rating from Toronto-based Corporate Knightsmagazine The company endeavors to become a global leader in the delivery of high-quality, sustainable cannabis The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), a company dedicated to producing organic cannabis using craft farming techniques, was one of the presenters at the Cannabis Investor Conference held by New West Partners on August 22, 2019, in San Francisco, California (http://ibn.fm/A4qjv). Based in Hamilton, Ontario, The Green Organic Dutchman is committed to become a global leader…

ThursdaySep 05, 2019 11:01 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Ever-Expanding Customer Base for DehydraTECH Drug Delivery Platform

Lexaria Bioscience recently announced its DehydraTECH(TM) patent for pharmaceutical applications of cannabinoids to treat certain disease conditions Lexaria Bioscience’s patented DehydraTECH drug delivery platform can be used to deliver nicotine, cannabinoids and many other useful substances The company has roughly 60 patents pending in countries around the world for its DehydraTECH drug delivery platform Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is at the forefront of the development of useful biotechnology products and has played a pivotal role in developing a way to deliver substances to the brain via non-inhalation methods through the development of a novel drug delivery platform. The…

ThursdaySep 05, 2019 10:22 am

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Building Global Cannabis Company Featuring Premier Plant-Based Health and Wellness Products

Wildflower Brands recently completed its acquisition of City Cannabis Corp. in a deal that includes four operating retail cannabis stores and renovations to additional locations Wildflower holds 14 licenses for cannabis cultivation, manufacturing, distribution and retail in California, the world’s largest cannabis market Expansion plans into Europe’s CBD market are underway via an agreement with Poland-based wellness distribution company Two Towers Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) continues its expansion of retail, online sales and production capacity in both Canada and the United States, building on its strategic goal of becoming a global wellness leader. Its recent acquisition of…

ThursdaySep 05, 2019 9:19 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Issues Corporate Update; Set to Present at H.C. Wainwright 21st Annual Global Investment Conference

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) on Tuesday issued an update regarding its clinical development programs, manufacturing and strategy for bringing its Oncoprex(TM) immunogene therapy to market. A corporate presentation is available on GNPX’s website which details anticipated milestones and future guidance for the company. “These milestones emphasize our commitment to developing potentially life-changing gene technologies for cancer patients who need them most,” Genprex chairman and chief executive officer Rodney Varner stated in the news release. “We continue to dedicate our efforts toward developing Oncoprex for non-small cell lung cancer (“NSCLC”) and we believe that achievement of these milestones…

Site Search

Company Search